These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29490499)

  • 21. Opioid Death Rate Acceleration in Jurisdictions Legalizing Marijuana Use-Reply.
    Bradford AC; Abraham A; Bagwell Adams G
    JAMA Intern Med; 2018 Sep; 178(9):1281-1282. PubMed ID: 30193247
    [No Abstract]   [Full Text] [Related]  

  • 22. Could Delaware's medical marijuana law reduce harms from opioid analgesics?
    Bachhuber MA; Saloner B; Cunningham CO; Feingold J; Barry CL
    Del Med J; 2014 Nov; 86(11):341-3. PubMed ID: 25647864
    [No Abstract]   [Full Text] [Related]  

  • 23. The prevalence and significance of cannabis use in patients prescribed chronic opioid therapy: a review of the extant literature.
    Reisfield GM; Wasan AD; Jamison RN
    Pain Med; 2009 Nov; 10(8):1434-41. PubMed ID: 19793342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DEA reschedules hydrocodone combination products.
    Pergolizzi JV
    Pain Pract; 2015 Feb; 15(2):95-7. PubMed ID: 25639283
    [No Abstract]   [Full Text] [Related]  

  • 25. Cannabis and opioid overdoses: time to move on and examine potential mechanisms.
    Rogeberg O; Blomkvist AW; Nutt D
    Addiction; 2018 Aug; 113(8):1551-1552. PubMed ID: 29882246
    [No Abstract]   [Full Text] [Related]  

  • 26. Patterns and correlates of medical cannabis use for pain among patients prescribed long-term opioid therapy.
    Nugent SM; Yarborough BJ; Smith NX; Dobscha SK; Deyo RA; Green CA; Morasco BJ
    Gen Hosp Psychiatry; 2018; 50():104-110. PubMed ID: 29153783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Approaches to Cannabis: A Narrative Review.
    Slawek DE; Curtis SA; Arnsten JH; Cunningham CO
    Med Clin North Am; 2022 Jan; 106(1):131-152. PubMed ID: 34823727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of Chronic Pain in the Aftermath of the Opioid Backlash.
    Kroenke K; Cheville A
    JAMA; 2017 Jun; 317(23):2365-2366. PubMed ID: 28494058
    [No Abstract]   [Full Text] [Related]  

  • 29. Incidence of nonmedical use of OxyContin and other prescription opioid pain relievers before and after the introduction of OxyContin with abuse deterrent properties.
    Cheng HG; Coplan PM
    Postgrad Med; 2018 Aug; 130(6):568-574. PubMed ID: 29978755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can Medical Cannabis Break the Painkiller Epidemic?
    Hsu J
    Sci Am; 2016 Aug; 315(3):10-12. PubMed ID: 27924878
    [No Abstract]   [Full Text] [Related]  

  • 31. Accuracy of Patient Opioid Use Reporting at the Time of Medical Cannabis License Renewal.
    Vigil JM; Stith SS; Reeve AP
    Pain Res Manag; 2018; 2018():5704128. PubMed ID: 29623144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence shows that cannabis has fewer relative harms than opioids.
    Lake S; SocĂ­as ME; Milloy MJ
    CMAJ; 2020 Feb; 192(7):E166-E167. PubMed ID: 32071110
    [No Abstract]   [Full Text] [Related]  

  • 33. In consideration of cannabis.
    Reiman A
    Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S208-S209. PubMed ID: 29464794
    [No Abstract]   [Full Text] [Related]  

  • 34. Medical cannabis and chronic opioid therapy.
    Reisfield GM
    J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):356-61. PubMed ID: 21133743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential public health impacts of medical cannabis availability on opioid-related harms? Urgent but un-answered questions from Canada.
    Fischer B; Jones W; Hall W; Kurdyak P
    Int J Drug Policy; 2019 Nov; 73():96-99. PubMed ID: 31404900
    [No Abstract]   [Full Text] [Related]  

  • 36. Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain.
    Boehnke KF; Litinas E; Clauw DJ
    J Pain; 2016 Jun; 17(6):739-44. PubMed ID: 27001005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marijuana Legalization: Impact on Physicians and Public Health.
    Wilkinson ST; Yarnell S; Radhakrishnan R; Ball SA; D'Souza DC
    Annu Rev Med; 2016; 67():453-66. PubMed ID: 26515984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does Medical Cannabis Use Increase or Decrease the Use of Opioid Analgesics and Other Prescription Drugs?
    Bachhuber MA; Arnsten JH; Cunningham CO; Sohler N
    J Addict Med; 2018; 12(4):259-261. PubMed ID: 29664894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The paradox of decreasing nonmedical opioid analgesic use and increasing abuse or dependence - An assessment of demographic and substance use trends, United States, 2003-2014.
    Jones CM
    Addict Behav; 2017 Feb; 65():229-235. PubMed ID: 27561431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discrepancies in prevalence estimates in two national surveys for nonmedical use of a specific opioid product versus any prescription pain reliever.
    Biondo G; Chilcoat HD
    Drug Alcohol Depend; 2014 Jan; 134():396-400. PubMed ID: 24210422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.